BioElectronics Corporation announced its distribution partner in Mexico has received authorization from Mexican FDA (Cofepris), which allows for the importation of the RecoveryRx® device into Mexico.e Novro Med S.A. de C.V. has contracted for the exclusive distribution rights for RecoveryRx® in Mexico. It is expected that they will receive their initial stocking order during the second quarter, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0002 USD | 0.00% |
|
+100.00% | 0.00% |
Mar. 25 | BioElectronics Corporation Announces the Results and Publication of A Canine Arthritis Study | CI |
Feb. 23 | Bioelectronics Corporation Announces the Publication of Pilot Study Results | CI |
1st Jan change | Capi. | |
---|---|---|
0.00% | 4.94M | |
+3.26% | 209B | |
+6.55% | 183B | |
+31.66% | 158B | |
+34.32% | 114B | |
+5.13% | 67.29B | |
+19.33% | 54.83B | |
-3.30% | 46.88B | |
-4.84% | 38.58B | |
+3.83% | 36.65B |
- Stock Market
- Equities
- BIEL Stock
- News BioElectronics Corporation
- BioElectronics’ RecoveryRx Pain Relief Device Receives Clearance from Cofepris, Launching Distribution in Mexico